Back to PharmaIndex

PANCREAZE

PANCRELIPASE (AMYLASE;LIPASE;PROTEASE)

Drug details

API

PANCRELIPASE (AMYLASE;LIPASE;PROTEASE)

Drug classification

Dosage form

CAPSULE, DELAYED RELEASE;ORAL

API strength per dosage

98,400USP UNITS; 16,800USP UNITS; 56,800USP UNITS

Dose

Mechanism of action

Indications

Side effects

Pregnancy category

Precautions

Contraindications

PharmaProLearn

Excel Beyond Limits